Patent US5041376A successfully refreshed from Google Patents.
US5041376A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for identifying or shielding functional sites or epitopes of proteins that enter the exocytotic pathway of eukaryotic cells, the mutant proteins so produced and genes encoding said mutant proteins
Assignee: Cold Spring Harbor Laboratory
•
Filing: 1988-12-09
•
Granted: 1991-08-20
•
Expires: 2008-12-09
Abstract
Abstract The present invention relates to a method for identifying or shielding functional sites or epitopes of proteins that enter the exocytotic pathway of eukaryotic cells (transportable proteins) by the addition of supernumerary N-linked oligosaccharide side chains at chosen sites on the surface thereof using oligonucleotide mutagenesis. The present invention also relates to mutant transportable proteins having supernumerary N-linked oligosaccharide side chains which shield functional sites or epitopes; and genes which encode the same.
Inventors
- 👤 Mary J. Gething
- 👤 Joseph F. Sambrook
- 👤 Patricia Gallagher
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 21:32
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; C07K16/00; C07K16/08; C07K16/10; C07K16/108; C12; C12N; C12N15/00; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6456; C12N9/6459; C12Y; C12Y304/00; C12Y304/21; C12Y304/21069; C12N2760/00; C12N2760/00011; C12N2760/16011; C12N2760/16022
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
172 words
A method for identifying or shielding functional sites or epitopes of a transportable protein comprising: (1) carrying out oligonucleotide-directed mutagenesis of selected nucleotides of the gene encoding said transportable protein so as to introduce DNA sequences encoding additional consensus amino acid sequence(s) for N-linked glycosylation by effecting a single amino acid mutation(s) on the exposed surface of said transportable protein; (2) transforming a eukaryotic cell with the resulting modified gene, wherein said eukaryotic cell expresses said modified gene and glycosylates said additional consensus amino acid sequence(s) so as to introduce additional N-linked oligosaccharide side chain(s) attached to asparagine residue(s) of the additional consensus amino acid sequence(s) located on the exposed surface of said transportable protein; (3) assaying the resulting modified transportable protein so as to determine if it possesses correct protein folding, wherein when correct protein folding has been confirmed; (4) assaying the modified transportable protein for inhibition of functional or epitopic activity so as to identify or confirm the shielding of the functional sites or epitopes, respectively, of said transportable protein.
Claim 2
Independent Claim
172 words
A method for identifying or shielding functional sites or epitopes of a transportable protein comprising: (1) carrying out oligonucleotide-directed mutagenesis of selected nucleotides of the gene encoding said transportable protein so as to introduce DNA sequences encoding additional consensus amino acid sequence(s) for N-linked glycosylation by effecting a single amino acid mutation(s) on the exposed surface of said transportable protein; (2) transforming a eukaryotic cell with the resulting modified gene, wherein said eukaryotic cell expresses said modified gene and glycosylates said additional consensus amino acid sequence(s) so as to introduce additional N-linked oligosaccharide side chain(s) attached to asparagine residue(s) of the additional consensus amino acid sequence(s) located on the exposed surface of said transportable protein; (3) assaying the resulting modified transportable protein so as to determine if it possesses correct protein folding, wherein when correct protein folding has been confirmed; (4) assaying the modified transportable protein for inhibition of functional or epitopic activity so as to identify or confirm the shielding of the functional sites or epitopes, respectively, of said transportable protein.
Claim 3
Dependent Claim
15 words
The method as claimed in claim 1, wherein said transportable protein is a membrane protein.
Claim 4
Dependent Claim
30 words
The method as claimed in claim 2, wherein said membrane protein is selected from the group consisting of an enzyme, a receptor, a transport protein, and a cell surface antigen.
Claim 5
Dependent Claim
15 words
The method as claimed in claim 1, wherein said transportable protein is a secretory protein.
Claim 6
Dependent Claim
36 words
The method as claimed in claim 4, wherein said secretory protein is selected from the group consisting of an enzyme, an enzyme inhibitor, a cell attachment protein, a hormone, a growth factor and a carrier protein.
Claim 7
Dependent Claim
17 words
The method as claimed in claim 1, wherein said transportable protein is a genetically engineered transportable protein.
References Cited (Backward Citations)
JPS6320083A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-08-19 | 1995-02-18 | 1995-08-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-08-19 | 1999-02-18 | 1999-08-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-08-19 | 2003-02-18 | 2003-08-20 | $7700.00 | Window Closed / Lapsed |